Funding was provided by Children's Miracle Network, National Institutes of Health, American Cancer Society and Clinical and Translational Science Institute.
Personalized treatment may help some liver cancer patients
2010-10-23
(Press-News.org) A more personalized treatment for people with a type of metastatic liver cancer --hepatocellular carcinoma -- may be possible by targeting the protein c-Met, according to Penn State College of Medicine researchers. Hepatocellular carcinoma (HCC) is the number three cause of cancer deaths in the world.
Hanning You, M.D., Ph.D., postdoctoral fellow, and C. Bart Rountree, M.D., assistant professor of pediatrics and pharmacology, targeted c-Met, a known receptor for hepatocyte growth factor, the substance that appears to drive liver cancer metastasis. In a pre-clinical translational study, they show that c-Met is overexpressed in metastatic liver cancer cells and is associated with a poor prognosis.
"In addition to finding that c-Met is a significant biomarker for liver cancer, we conducted an analysis of six published manuscripts and 1,051 patients," said You. "Through this analysis we demonstrated and confirmed that c-Met activation is strongly associated with poor prognosis and aggressive features in patients with liver cancer tumors."
Currently, physicians treat hepatocellular carcinoma with a "one size fits all" approach, so targeting c-Met may be an effective therapy for some patients.
"The five-year-survival of HCC is only 2 percent when diagnosed after metastasis," said Rountree. "Sorafenib, the most recently approved mediation for advanced HCC, benefits patients with an extra two months survival."
By targeting c-Met, researchers suppressed tumor growth and proliferation in a mouse model. They believe that molecular profiling will allow better treatment for the 45 percent of HCC patients who have c-Met positive tumors.
The research team is now looking to apply their findings to HCC in humans. The lab has applied to the National Cancer Institute to join a phase I trial using a c-Met inhibitor for advanced HCC.
"We are also working to build a second trial where we will establish a molecular profile of HCC patients before we start treatment, and then only give the c-Met inhibitor to the patients with a c-Met positive tumor, in effect personalizing their therapy," Rountree said.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
Rapid rise in Medicaid expenditures for autism spectrum disorder treatment
2010-10-23
Washington, DC, 22 October 2010 — Autism was described as early as 1940, but a marked increase in the prevalence for the broader class of autism spectrum disorders (ASDs) during the past decade highlights the demand for treatment of affected individuals. The Centers for Disease Control and Prevention (CDC) reported that the prevalence of ASD was one in 110 children in 2006 and increased at an average annual rate of 57% between 2002 and 2006.1 The rising prevalence has heightened concern about the financial impact of treating ASDs in the private and public health care ...
Swine flu variant linked to fatal cases might have disabled the clearing mechanism of lungs
2010-10-23
A variant of last year's pandemic influenza linked to fatal cases carried a mutation that enabled it to infect a different subset of cells lining the airway, according to new research. The study, due to be published next week in the Journal of Virology, suggests that the mutant virus could have impaired the lungs' ability to clear out germs. The researchers behind the study, from Imperial College London, the Medical Research Council National Institute for Medical Research and the University of Marburg said the findings highlight the potential for deadlier strains of flu ...
Parents experience difficulty with consent process in pediatric cancer trials
2010-10-23
BOSTON—Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Parents who had agreed to their children's enrollment in treatment trials said they felt hurried in making the decision, the researchers said. They also perceived themselves ...
Bankers got a kick out of the Crunch, says academic
2010-10-23
The bankers who brought the global economy to its knees two years ago may have enjoyed the sensation of losing hundreds of billions of pounds and plunging the world into recession, according to an academic at Cardiff University.
In an article published in Angelaki: Journal of the Theoretical Humanities, Dr Paul Crosthwaite claims that the willingness of banks to deal in sub-prime loans and related derivatives, which were bound to result in disastrous losses, can only be understood if the bankers unconsciously desired the destruction of their own institutions. Such catastrophic ...
Energy saving lamp is eco-winner
2010-10-23
Since September 1st, 2009 the sale and import of incandescent light bulbs – more accurately known as tungsten filament bulbs – with the lowest energy efficiency classifications F and G have been banned in Switzerland. In addition, on the same day this country also adopted the EU's incandescent light bulb ban, which legislates for a step-by-step phasing-out of these inefficient light sources. In accordance with the new EU rules, 100 Watt bulbs were banned on September 1st, 2009, and a year later all bulbs rated between 75 and 100 Watts will be withdrawn from the market. ...
UT professor finds economic inequality is self-reinforcing
2010-10-23
When the gap between the haves and have-nots gets larger, one would think the have-nots would want more help, most likely in the form of government programs, to fight rising inequities.
Not so, says Nate Kelly, assistant professor of political science at the University of Tennessee, Knoxville.
Kelly, along with Peter Enns of Cornell University, conducted a study analyzing economic inequality and public opinion toward government intervention. The study has been published in the October edition of the American Journal of Political Science and can be viewed by visiting ...
Genetics work could lead to advances in fertility for women
2010-10-23
Princeton scientists have identified genes responsible for controlling reproductive life span in worms and found they may control genes regulating similar functions in humans.
The work suggests that someday researchers may be able to develop ways to maintain fertility in humans, allowing women who want to delay having children to preserve that capacity and extend their reproduction, and to prevent maternal age-related birth defects.
The research, led by Coleen Murphy, an assistant professor of molecular biology and the Lewis-Sigler Institute for Integrative Genomics, ...
70-year-olds smarter than they used to be
2010-10-23
Today´s 70-year-olds do far better in intelligence tests than their predecessors. It has also become more difficult to detect dementia in its early stages, though forgetfulness is still an early symptom, reveals new research from the University of Gothenburg, Sweden, based on the H70 study.
The H70 study provides data on cognitive symptoms that researchers have used to predict the development of dementia, and also to investigate whether the symptoms have changed in recent generations. The study involves a large proportion of 70-year-olds from Gothenburg, Sweden, who have ...
UMMS biomedical researchers develop more reliable, less expensive synthetic graft material
2010-10-23
WORCESTER, Mass. – With a failure rate as high as 50 percent, bone tissue grafts pose a significant obstacle to orthopedic surgeons attempting to repair complex fractures or large areas of bone loss, such as those often caused by trauma and cancer. Current synthetic substitutes rarely possess the bone-like properties needed for successful grafting and are often difficult for surgeons to manipulate in the operating room. In response to these challenges, researchers at UMass Medical School have developed an easy-to-produce, inexpensive, synthetic bone material called FlexBone. ...
Vaccines could help what's ailing fish
2010-10-23
U.S. Department of Agriculture (USDA) scientists are developing vaccines to help protect healthy farm-raised catfish against key diseases.
Working as a team, microbiologist Phillip H. Klesius and molecular biologists Julia Pridgeon and Craig Shoemaker with USDA's Agricultural Research Service (ARS) at the agency's Aquatic Animal Health Research Unit in Auburn, Ala., and Joyce J. Evans, aquatic pathologist at the Auburn unit's lab in Chestertown, Md., are developing vaccines against Streptococcus iniae, S. agalactiae and other pathogens.
ARS is USDA's principal intramural ...